Like it or not, Obamacare forces drug company disclosure - News - ReviewJournal.com:
The New York Times and the Wall Street Journal have taken the lead in writing about potential conflicts of interest between doctors and medical manufacturers. Although philosophically on opposite sides, both newspapers have raised questions in chilling stories about doctors taking money from drug and device manufacturers.
The Times' reported that some doctors practice medicine differently if they take money and are more willing to prescribe drugs in risky and unapproved ways.
In the regulations being finalized, executives at the top would be responsible for the accuracy for that disclosure. The information would be on a searchable website so the public can check it out. About 1,100 companies would have to file reports.
Every transaction may not be dubious, but when more than one out of four doctors are paid for consulting, lectures or enrolling patients in clinical trials, you deserve to know if your doctor might have a financial interest in a particular company.
- Sent using Google Toolbar Sphere: Related Content
1 comment:
Post a Comment